In a significant stride toward revolutionizing treatments for dietary-related metabolic diseases, Antag Therapeutics has successfully raised $115 million in its latest funding round. The company, rooted in groundbreaking collaborative research from the University of Copenhagen, is dedicated to developing novel therapeutic solutions that harness the power of naturally occurring peptides. Spearheaded by renowned researchers, Professors Mette M. Rosenkilde and Jens J. Holst, Antag Therapeutics has pioneered a range of innovative strategies derived from their extensive studies, with several of these naturally occurring peptides currently undergoing rigorous human trials. This funding milestone marks a pivotal moment in the company’s trajectory, positioning it to accelerate clinical development and expand its research efforts. The capital will be allocated toward advancing their promising pipeline of treatments aimed at combating metabolic disorders that afflict millions globally, including obesity and Type 2 diabetes. With a commitment to transforming patient outcomes through precision medicine, Antag Therapeutics is well poised to make a significant impact in the biopharmaceutical landscape. As the company moves forward, they remain focused on translating their world-class research into accessible and effective therapeutic options, ultimately improving the quality of life for those affected by metabolic challenges. The backing from investors not only underscores their confidence in Antag Therapeutics’ vision but also marks a robust endorsement of the company’s scientific foundation and its potential to innovate within the metabolic disorder treatment space.
Breaking News: Maze Therapeutics Secures $115 Million in Funding for Antag Therapeutics' Novel Treatments for Metabolic Diseases
Recently funded · $115.0MBiotechnology
Get the full Maze Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
